| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |